Back to Results
First PageMeta Content
Corporate crime / Dow Jones Industrial Average / Pfizer / Cynapsus Therapeutics / Thin film drug delivery / Galderma / APL / Pharmaceutical industry / Listerine / Pharmaceutical sciences / Pharmacology / Computing


PRESS RELEASE Cynapsus Therapeutics Announces Hiring of New Chief Scientific Officer and EVP, CMC October 7, 2014 TORONTO, CANADA – (Marketwired) – Cynapsus Therapeutics (CTH: TSXV) (CYNAF: OTCQX), a specialty pharma
Add to Reading List

Document Date: 2014-10-15 09:40:48

Open Document

File Size: 211,25 KB

Share Result on Facebook

City

TORONTO / /

Company

Nestle Skin Health S.A. / Galderma Pharma S.A. / Novartis / Galderma Manufacturing / Alcon Laboratories / Cynapsus Therapeutics / TSX Venture Exchange / Oral Thin Films / Pfizer Global Manufacturing / CMC October / Cynapsus Therapeutics Cynapsus / Contact Information Cynapsus Therapeutics Anthony Giovinazzo / /

Continent

Asia / Europe / /

Country

France / Japan / United States / Canada / /

/

Event

Product Release / FDA Phase / Employment Change / Reorganization / /

IndustryTerm

pharmaceutical development / cosmetic products / drug product / scientific and commercial manufacturing leadership / internal/contract manufacturing sites / technology due diligence / pharmaceutical / topical and liquid drug products / manufacturing / technology platforms / manufacturing technology screening / technology transfer / /

MedicalCondition

Parkinson's disease / MS / disease / Parkinson’s disease / chronic and progressive neurodegenerative disease / Cough Cold Allergy / /

Organization

Technical Operations Division / /

Person

Anthony Giovinazzo / Thierry Bilbault / Andrew Williams / /

/

Position

Vice President / Chief Scientific Officer and EVP / development and manufacturing operations leader / Technical Director / Industrial Development Director / Vice President of Chemistry / COO & CFO / Chief Scientific Officer / President and CEO / President and Chief Executive officer / Executive Vice President / Vice President New Technology and Product Innovation / /

Product

APL-130277 / Hiring / DR tablets / APL-130277 drug product / Triaminic / Nicotine / Dr / /

ProvinceOrState

Mississippi / /

PublishedMedium

Molecular and Cellular Biology / /

Technology

API / drug delivery / drug development / /

URL

www.sedar.com / www.cynapsus.ca / /

SocialTag